These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8725623)

  • 21. Association of dialyzer reuse and hospitalization rates among hemodialysis patients in the US.
    Feldman HI; Bilker WB; Hackett M; Simmons CW; Holmes JH; Pauly MV; Escarce JJ
    Am J Nephrol; 1999; 19(6):641-8. PubMed ID: 10592357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dialyzer reprocessing with peroxyacetic acid as sole cleansing and sterilizing agent.
    Kes P; Reiner Z; Ratković-Gusić I
    Acta Med Croatica; 1997; 51(2):87-93. PubMed ID: 9204593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experience with the multiple use of dialyzers].
    Strokov AG; Poz IaL; Baeva LB; Levitskiĭ ER; Annenkov AE; Rud'ko IA; Kubatiev AA
    Ter Arkh; 1994; 66(6):60-5. PubMed ID: 7940372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
    Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
    Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reprocessing and multiple use of hemodialyzers: a critical appraisal.
    Kes P
    Acta Med Croatica; 1994; 48(3):129-39. PubMed ID: 7532049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodialyzer Reuse and Gram-Negative Bloodstream Infections.
    Edens C; Wong J; Lyman M; Rizzo K; Nguyen D; Blain M; Horwich-Scholefield S; Moulton-Meissner H; Epson E; Rosenberg J; Patel PR
    Am J Kidney Dis; 2017 Jun; 69(6):726-733. PubMed ID: 27940061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dialyzer reuse with peracetic acid does not impact patient mortality.
    Bond TC; Nissenson AR; Krishnan M; Wilson SM; Mayne T
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1368-74. PubMed ID: 21566107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis.
    Vanholder RC; Ringoir SM
    Blood Purif; 1990; 8(1):32-44. PubMed ID: 2198890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dialysis prescription: reuse.
    Maidment HJ; Petersen J
    Am J Nephrol; 1996; 16(1):52-9. PubMed ID: 8719766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in bio-incompatibility among four biocompatible dialyzer membranes using in maintenance hemodialysis patients.
    Zhang DL; Liu J; Cui WY; Ji DY; Zhang Y; Liu WH
    Ren Fail; 2011; 33(7):682-91. PubMed ID: 21787159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plate, coil, and hollow-fiber cuprammonium cellulose dialyzers: discrepancy between incidence of anaphylactic reactions and degree of complement activation.
    Daugirdas JT; Potempa LD; Dinh N; Gandhi VC; Ivanovich PT; Ing TS
    Artif Organs; 1987 Apr; 11(2):140-3. PubMed ID: 3593043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta 2-microglobulin kinetics in maintenance hemodialysis: a comparison of conventional and high-flux dialyzers and the effects of dialyzer reuse.
    DiRaimondo CR; Pollak VE
    Am J Kidney Dis; 1989 May; 13(5):390-5. PubMed ID: 2655439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Technical challenges to successful dialyzer reuse.
    Ward RA
    Blood Purif; 1995; 13(3-4):153-9. PubMed ID: 7619387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biocompatibility of haemodialysis membranes.
    van Berlo A; Ellens DJ
    Adv Exp Med Biol; 1988; 238():341-58. PubMed ID: 3074642
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of peracetic acid reprocessing on the transport characteristics of polysulfone hemodialyzers.
    Wolff SH; Zydney AL
    Artif Organs; 2005 Feb; 29(2):166-73. PubMed ID: 15670286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A quality and cost-benefit analysis of dialyzer reuse in hemodialysis patients.
    Chuang FR; Lee CH; Chang HW; Lee CN; Chen TC; Chuang CH; Chiou TT; Wu CH; Yang CC; Wang IK
    Ren Fail; 2008; 30(5):521-6. PubMed ID: 18569933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dialyzer reuse: justified cost saving for south Asian region.
    Dhrolia MF; Nasir K; Imtiaz S; Ahmad A
    J Coll Physicians Surg Pak; 2014 Aug; 24(8):591-6. PubMed ID: 25149841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retention of cytokine-inducing substances inside high-flux dialyzers.
    Lufft V; Mahiout A; Shaldon S; Koch KM; Schindler R
    Blood Purif; 1996; 14(1):26-34. PubMed ID: 8718562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of dialyzer reuse on the permeability of low-flux membranes.
    Matos JP; André MB; Rembold SM; Caldeira FE; Lugon JR
    Am J Kidney Dis; 2000 May; 35(5):839-44. PubMed ID: 10793017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of dialyzer reuse on dialysis delivery.
    Sherman RA; Cody RP; Rogers ME; Solanchick JC
    Am J Kidney Dis; 1994 Dec; 24(6):924-6. PubMed ID: 7985670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.